Similar HIV protection from four weeks of zidovudine versus nevirapine prophylaxis among formula-fed infants in Botswana.

Similar HIV protection from four weeks of zidovudine versus nevirapine prophylaxis among formula-fed infants in Botswana.
复制标题

DOI:
10.4102/sajhivmed.v19i1.751
复制
发表时间:
2018
影响因子:
1.7
通讯作者:
Shapiro RL
Shapiro RL
中科院分区:
医学4区
文献类型:
--
作者:
Powis KM;Lockman S;Ajibola G;Hughes MD;Bennett K;Leidner J;Batlang O;Botebele K;Moyo S;van Widenfelt E;Makhema J;Petlo C;Jibril HB;McIntosh K;Essex M;Shapiro RL

文献摘要

参考文献

相似文献

世界卫生组织艾滋病毒指南建议婴儿齐多夫定(ZDV)或奈韦拉平(NVP)预防配方奶粉喂养的婴儿分娩期间母婴艾滋病毒传播(MTCT)。尚无研究评价ZDV每日两次与NVP每日一次在单纯配方奶粉喂养的HIV暴露婴儿中预防的比较疗效。使用来自Mpepu研究(一项在博茨瓦纳开展的临床试验,旨在研究预防性复方新诺明是否能改善婴儿存活率)的数据,对足月出生(妊娠≥ 37周)、出生体重≥ 2500 g且从出生起就接受配方奶粉喂养的婴儿进行了MTCT事件和AIDS部(DAIDS)3级或4级贫血或中性粒细胞减少症发生率的回顾性分析。从Mpepu研究开始,就使用ZDV婴儿预防。研究中途的方案修改导致随后使用NVP婴儿预防。在有资格进行二次回顾性分析的婴儿中,共有695名(52%)婴儿接受了ZDV,而646名(48%)婴儿从出生起接受了NVP至少25天但不超过35天。两名(0.29%)ZDV接受者和三名(0.46%)NVP接受者发生了确诊的分娩期HIV感染(p = 0.68)。19例(2.7%)ZDV接受者与12例(1.9%)NVP接受者发生贫血(p = 0.36)。28例(4.0%)ZDV接受者与21例(3.3%)NVP接受者发生中性粒细胞减少(p = 0.47)。在出生体重≥ 2500 g的配方奶粉喂养的足月婴儿中,ZDV和NVP均导致产时传播率较低,重度婴儿血液学毒性(DAIDS 3级或4级)无显著差异。
The World Health Organization HIV guidelines recommend either infant zidovudine (ZDV) or nevirapine (NVP) prophylaxis for the prevention of intrapartum mother-to-child HIV transmission (MTCT) among formula-fed infants. No study has evaluated the comparative efficacy of infant prophylaxis with twice daily ZDV versus once daily NVP in exclusively formula-fed HIV-exposed infants. Using data from the Mpepu Study, a Botswana-based clinical trial investigating whether prophylactic co-trimoxazole could improve infant survival, retrospective analyses of MTCT events and Division of AIDS (DAIDS) Grade 3 or Grade 4 occurrences of anaemia or neutropenia were performed among infants born full-term (≥ 37 weeks gestation), with a birth weight ≥ 2500 g and who were formula-fed from birth. ZDV infant prophylaxis was used from Mpepu Study inception. A protocol modification mid-way through the study led to the subsequent use of NVP infant prophylaxis. Among infants qualifying for this secondary retrospective analysis, a total of 695 (52%) infants received ZDV, while 646 (48%) received NVP from birth for at least 25 days but no more than 35 days. Confirmed intrapartum HIV infection occurred in two (0.29%) ZDV recipients and three (0.46%) NVP recipients (p = 0.68). Anaemia occurred in 19 (2.7%) ZDV versus 12 (1.9%) NVP (p = 0.36) recipients. Neutropenia occurred in 28 (4.0%) ZDV versus 21 (3.3%) NVP recipients (p = 0.47). Both ZDV and NVP resulted in low intrapartum transmission rates and no significant differences in severe infant haematologic toxicity (DAIDS Grade 3 or Grade 4) among formula-fed full-term infants with a birthweight ≥ 2500 g.
DOI: 10.1056/nejmoa0911486
发表时间: 2010-06-17
期刊: The New England journal of medicine
影响因子: --
作者:
Chasela CS;Hudgens MG;Jamieson DJ;Kayira D;Hosseinipour MC;Kourtis AP;Martinson F;Tegha G;Knight RJ;Ahmed YI;Kamwendo DD;Hoffman IF;Ellington SR;Kacheche Z;Soko A;Wiener JB;Fiscus SA;Kazembe P;Mofolo IA;Chigwenembe M;Sichali DS;van der Horst CM;BAN Study Group
通讯作者: BAN Study Group
DOI: 10.1111/j.1440-1754.1997.tb01022.x
发表时间: 1997-04-01
影响因子: 1.7
作者:
Tapp, H;Savarirayan, R
通讯作者: Savarirayan, R
DOI: 10.1111/hiv.12185
发表时间: 2014-09-01
期刊: HIV MEDICINE
影响因子: 3
作者:
de Ruiter, Annemiek;Taylor, Graham P.;Wilkins, Ed
通讯作者: Wilkins, Ed
DOI: 10.1056/nejmoa0801941
发表时间: 2008-07-10
影响因子: 158.5
作者:
Kumwenda, Newton I.;Hoover, Donald R.;Taha, Taha E.
通讯作者: Taha, Taha E.